# NVision Quantum Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nvision-quantum-technologies

- Industry: Healthcare
- Headquarters: Ulm, Germany
- Website: www.nvision-quantum.com
- Total disclosed funding: $68M
- Latest round: Series A (Jan 17, 2025)
- Investors on record: 11

## About

Based in Ulm, Germany, and founded in 2015, NVision Quantum Technologies GmbH operates as a developer of quantum technology designed to enhance medical imaging and detect the effects of cancer therapy at the tissue level. The company was co-founded by Ilai Schwartz (CTO), Martin Plenio, and Alex Retzker. As of 2023, the company is led by its CEO, Sella Brosh, MD. In May 2026, NVision Quantum Technologies GmbH raised USD 38 million in series B funding from Abbott Capital Management, Matterwave Ventures Management, b2venture, CDP Venture Capital, Entree Capital, and Playground Ventures. The round was part of a larger USD 55 million series B and venture debt funding.

The company offers polarizers utilizing a method called parahydrogen-induced polarization (PHIP), leveraging advancements in quantum physics, chemistry, and engineering to transform metabolic MRIs that allow for early diagnosis and quicker assessment of treatment effectiveness. By employing hyperpolarization technology, the company enables the evaluation of human and animal metabolism through standard MRI, thereby facilitating applications in both preclinical and clinical settings. These include cancer diagnosis methods and the monitoring of therapy response. 

The company plans to use the May 2026 funding to expand its platform from quantum sensing into quantum computing to support drug design and therapy validation.

## Funding rounds

- Series A, Jan 17, 2025, $38M — Abbott Capital Management, CDP Venture Capital, Glocap, b2venture, Entree Capital, Playground Ventures, Sparkassenkapital Ulm
- Series A, Dec 21, 2022, $30M — Leonard Lauder, b2venture, Entree Capital, Pathena, Playground Ventures, ES Kapital, Zenoo Limited, Sparkassenkapital Ulm

## Investors

- Leonard Lauder — Series A
- b2venture (https://capitalatlas.ai/funds/b2venture) — Series A
- Entree Capital (https://capitalatlas.ai/funds/entree-capital) — Series A
- Pathena (https://capitalatlas.ai/funds/pathena) — Series A
- Playground Ventures (https://capitalatlas.ai/funds/playground-ventures) — Series A
- ES Kapital (https://capitalatlas.ai/funds/es-kapital) — Series A
- Zenoo Limited — Series A
- Sparkassenkapital Ulm (https://capitalatlas.ai/funds/sparkassenkapital-ulm) — Series A
- Abbott Capital Management (https://capitalatlas.ai/funds/abbott-capital-management) — Series A
- CDP Venture Capital (https://capitalatlas.ai/funds/cdp-venture-capital) — Series A
- Glocap — Series A